Microbot Medical Inc (NASDAQ:MBOT)’s share price traded down 5% during mid-day trading on Tuesday . The stock traded as low as $8.60 and last traded at $8.74. 784,400 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 5,757,591 shares. The stock had previously closed at $9.20.
Several equities analysts recently issued reports on the company. ValuEngine cut Microbot Medical from a “buy” rating to a “hold” rating in a report on Tuesday, January 15th. LADENBURG THALM/SH SH cut Microbot Medical from a “buy” rating to a “hold” rating and set a $1.75 price target on the stock. in a report on Monday, November 19th. They noted that the move was a valuation call.
Microbot Medical (NASDAQ:MBOT) last released its earnings results on Wednesday, November 14th. The biotechnology company reported ($0.58) earnings per share for the quarter, beating the consensus estimate of ($0.60) by $0.02.
About Microbot Medical (NASDAQ:MBOT)
Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.
Featured Article: Retained Earnings
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.